ALAlphabet Inc.
Institutional investor · Portfolio as of Q2 2021
Top Holdings36 positions
UIPATH INC CLASS A | 29M | $2B | 40.2% | $67.93 | 0.00% | 1 qtr | New 99 |
VERVE THERAPEUTICS INC | 11M | $661.2M | 13.5% | — | — | 1 qtr | New 98 |
OSCAR HEALTH INC CLASS A | 24M | $516.9M | 10.5% | $26.88 | -20.01% | 2 qtrssince 2021-Q1 | Unchanged 0 |
LYFT INCA | 6.1M | $371.2M | 7.6% | $40.84 | +48.09% | 8 qtrssince 2019-Q3 | Decreased 0 |
DEXCOM INC | 805,681 | $344M | 7.0% | $52.30 | +104.10% | 8 qtrssince 2019-Q3 | Unchanged 0 |
Desktop Metal Inc | 11M | $127.1M | 2.6% | — | — | 3 qtrssince 2020-Q4 | Decreased 0 |
ARCUS BIOSCIENCES INC | 4.6M | $126.7M | 2.6% | $9.10 | +201.76% | 8 qtrssince 2019-Q3 | Decreased 0 |
LYELL IMMUNOPHARMA INC | 5.9M | $95.3M | 1.9% | $324.80 | 0.00% | 1 qtr | New 69 |
BEAM THERAPEUTICS INC | 635,586 | $81.8M | 1.7% | $18.00 | +615.06% | 6 qtrssince 2020-Q1 | Decreased 0 |
AIRBNB INC | 525,626 | $80.5M | 1.6% | $146.80 | +14.27% | 3 qtrssince 2020-Q4 | Decreased 0 |
RELAY THERAPEUTICS INC | 1.8M | $66.8M | 1.4% | $41.74 | -12.34% | 4 qtrssince 2020-Q3 | Increased 55 |
Slack Technologies Inc. | 1.3M | $57.6M | 1.2% | — | — | 8 qtrssince 2019-Q3 | Unchanged 0 |
SANA BIOTECHNOLOGY INC | 2.8M | $55.3M | 1.1% | $33.47 | -41.26% | 2 qtrssince 2021-Q1 | Unchanged 0 |
CLOVER HEALTH INVESTMENTS CO | 4.1M | $54.8M | 1.1% | $7.56 | -2.25% | 2 qtrssince 2021-Q1 | Unchanged 0 |
KRONOS BIO INC | 1.4M | $34.4M | 0.7% | — | — | 3 qtrssince 2020-Q4 | Unchanged 0 |
MONTE ROSA THERAPEUTICS INC | 1.5M | $33.2M | 0.7% | $22.70 | 0.00% | 1 qtr | New 57 |
| 3.3M | $32.7M | 0.7% | — | — | 8 qtrssince 2019-Q3 | Unchanged 0 | |
BARINTHUS BIOTHERAPEUTICS PL | 1.7M | $28.6M | 0.6% | $14.33 | 0.00% | 1 qtr | New 57 |
RAPT THERAPEUTICS INC | 788,813 | $25.1M | 0.5% | — | — | 7 qtrssince 2019-Q4 | Decreased 0 |
Singular Genomics Systems Inc | 646,622 | $17.8M | 0.4% | — | — | 1 qtr | New 48 |
Alphabet Inc. manages $4.9B across 36 positions as of Q2 2021. Top holdings: PATH (40.2%), VERV (13.5%), OSCR (10.5%). Fund DNA: Concentrated Value. HoldingsIntel Score: 2.5/5.0.
Added PATH, VERV, LYEL and 5 more; exited UPST, OPEN, LMND and 1 more; increased 1, led by RLAY (+258,390 shares); trimmed 7, led by ABNB (−165,986 shares). Top move: PATH (NEW, conviction 99). Portfolio: $4.9B across 36 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Famous Investors' Portfolios
What the most-followed managers hold, and what they bought and sold each quarter.
- Warren Buffett (Chairman Emeritus)Berkshire Hathaway
- Leopold AschenbrennerSituational Awareness
- Michael BurryScion Asset Management
- Cathie WoodARK Invest
- Bill AckmanPershing Square
- Stanley DruckenmillerDuquesne Family Office
- David TepperAppaloosa
- Ray Dalio (Founder)Bridgewater Associates
- Li LuHimalaya Capital
- Carl IcahnCarl C. Icahn
- Brad GerstnerAltimeter Capital
- Seth KlarmanThe Baupost Group
- Howard Marks (Co‑founder)Oaktree Capital Management
- Ken GriffinCitadel
- Paul Tudor JonesTudor Investment Corp
- George Soros (Founder)Soros Fund Management
- Steve CohenPoint72
- Terry SmithFundsmith
- Ken Fisher (Founder)Fisher Investments
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR